title: Preparation and in vivo study of dry powder microspheres for nasal immunization.
abstract: The immunoadjuvant potential of alginate microspheres as delivery system, and cross-linked dextran microspheres (CDM) as absorption enhancer and excipient for powder of alginate microspheres, were evaluated. Alginate microspheres were prepared by emulsification method. Microspheres encapsulated with tetanus toxoid (TT) or Quillaja saponin (QS) were nasally administered to rabbits, three times in 2 weeks interval and serum IgG and nasal lavage sIgA titers were determined by ELISA. The mean diameter of microspheres was about 1.5 mum. Release of TT and QS was 13.1 +/- 1.4% and 31.8 +/- 4.3% after 4 h. The serum IgG titer induced with (TT)(ALG) microspheres was higher than TT solution (P<0.001). Addition of QS or CDM adjuvant, in separate, to (TT)(ALG) microspheres could not significantly increase the immune responses (P>0.05), but the highest systemic IgG titers induced with (TT+QS)(ALG)+CDM (P<0.01). The sIgA titer induced with (TT)(ALG) microspheres was higher than TT solution (P<0.05). The highest mucosal sIgA titers were seen in animals immunized with (TT)(ALG)+CDM (P<0.05). Co-encapsulation of QS and TT in microspheres did not increase the sIgA titers. When CDM was added to alginate microspheres encapsulated with TT or TT+QS, the highest mucosal and systemic responses were observed.
authors.affiliation: School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. tafaghodim@mums.ac.ir
authors.forename: Mohsen
authors.initials: M
authors.lastname: Tafaghodi
authors.forename: Somayeh
authors.initials: S
authors.lastname: Rastegar
mesh_terms: D000276:Adjuvants, Immunologic; D000281:Administration, Intranasal; D000464:Alginates / Q000737:chemistry*; D000818:Animals; D003432:Cross-Linking Reagents / Q000737:chemistry; D003911:Dextrans / Q000737:chemistry*; D004337:Drug Carriers / Q000737:chemistry; D004797:Enzyme-Linked Immunosorbent Assay; D005079:Excipients / Q000737:chemistry; D005260:Female; D020723:Glucuronic Acid / Q000737:chemistry; D006603:Hexuronic Acids / Q000737:chemistry; D007071:Immunoglobulin A, Secretory / Q000276:immunology; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D008863:Microspheres; D010316:Particle Size; D031990:Quillaja / Q000737:chemistry; D011817:Rabbits; D012503:Saponins / Q000008:administration & dosage / Q000276:immunology*; D013745:Tetanus Toxoid / Q000008:administration & dosage / Q000276:immunology*; D014612:Vaccines / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D000464:Alginates; D003432:Cross-Linking Reagents; D003911:Dextrans; D004337:Drug Carriers; D005079:Excipients; D006603:Hexuronic Acids; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G; D012503:Saponins; D013745:Tetanus Toxoid; D014612:Vaccines; D020723:Glucuronic Acid; C025614:sephadex